Licences

No deals are published yet. Deals found in 8-K filings wait for an editor to check them before they show here.

Read the deal news below

Deals from 8-K filings: Source: SEC EDGAR. A value reads "Not disclosed" until an editor enters an amount the source states.

Deal news

Merger and acquisition releases from PR Newswire, kept to health-industry companies.

  1. Acquisition expands Principle's bedside imaging services for long-term care providers in Missouri and Illinois (opens in a new tab)

    Principle Health Systems via PR Newswire

    HOUSTON, Oct. 30, 2026 /PRNewswire/ -- Principle Health Systems, a major provider of mobile diagnostic services to long-term care facilities across the Southern and Central United States, announced the acquisition of select assets from a mobile diagnostic imaging company serving the...

    Comments on Acquisition expands Principle's bedside imaging services for long-term care providers in Missouri and Illinois
  2. Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. (opens in a new tab)

    Viatris Inc. via PR Newswire

    PITTSBURGH, Oct. 30, 2026 /PRNewswire/ -- Viatris Inc. ("Viatris") (Nasdaq: VTRS), a global healthcare company, today announced that Peach Purchaser Sub Inc. ("Purchaser"), a wholly owned subsidiary of Viatris, has commenced a tender offer to purchase all of the issued and outstanding...

    Comments on Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.
  3. PeierTech Announces Completion of Majority Investment by HSG (opens in a new tab)

    PeierTech via PR Newswire

    HSG acquires approximately 80% of PeierTech, with existing management retaining an ownership stake and continuing to lead operations JIANGYIN, China, Oct. 29, 2026 /PRNewswire/ -- PeierTech, a manufacturer of medical-grade nitinol materials and precision components, today announced that...

    Comments on PeierTech Announces Completion of Majority Investment by HSG
  4. Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade (opens in a new tab)

    Perrigo Company plc via PR Newswire

    Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplification Furthers Perrigo's evolution into a simpler, more focused consumer self-care company Expected to enhance Perrigo's margin profile and eliminate significant expected future capital expenditures Aligns...

    Comments on Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade
  5. CaringKind Completes Merger, Strengthening Long Island Care as National Reach Grows (opens in a new tab)

    CaringKind via PR Newswire

    Local care and community relationships continue under the CaringKind name, connecting Nassau and Suffolk County families to a broader network of support. NEW YORK, Oct. 29, 2026 /PRNewswire/ -- CaringKind, a trusted partner in Alzheimer's and dementia care for nearly 50 years, has...

    Comments on CaringKind Completes Merger, Strengthening Long Island Care as National Reach Grows
  6. DCN Dx Acquires Human Biospecimen Provider BioSouthTech to Broaden Access to Diverse Patient Populations (opens in a new tab)

    DCN Dx via PR Newswire

    Latin American collection network and banked specimens support broader patient representation and earlier-stage cancer research CARLSBAD, Calif., Oct. 29, 2026 /PRNewswire/ -- DCN Dx today announced its acquisition of BioSouthTech, Inc., a human biospecimen provider headquartered in the...

    Comments on DCN Dx Acquires Human Biospecimen Provider BioSouthTech to Broaden Access to Diverse Patient Populations
  7. Transpharmation Ltd. gibt strategische Übernahme von OrganoTherapeutics SARL bekannt (opens in a new tab)

    Transpharmation Ltd. via PR Newswire

    TORONTO, 28. Oktober 2026 /PRNewswire/ -- Transpharmation Ltd., ein wissenschaftlich orientiertes, weltweit führendes Unternehmen im Bereich der präklinischen Auftragsforschung zu Neurowissenschaften, Schmerztherapie und Stoffwechselerkrankungen, freut sich, die Übernahme von...

    Comments on Transpharmation Ltd. gibt strategische Übernahme von OrganoTherapeutics SARL bekannt
  8. Transpharmation Ltd. annonce l'acquisition stratégique d'OrganoTherapeutics SARL (opens in a new tab)

    Transpharmation Ltd. via PR Newswire

    TORONTO, 28 octobre 2026 /PRNewswire/ -- Transpharmation Ltd., un chef de file mondial axé sur la science dans le domaine de la recherche préclinique sous contrat en neurosciences, dans le domaine de la douleur et des maladies métaboliques, est heureux d'annoncer l'acquisition...

    Comments on Transpharmation Ltd. annonce l'acquisition stratégique d'OrganoTherapeutics SARL
  9. Companion Spine Announces Completion of Paradigm Spine Integration, Establishing a Unified Global Leader in Posterior Dynamic and Controlled Motion Spine Solutions (opens in a new tab)

    Companion Spine USA LLC via PR Newswire

    Companion Spine completes the integration of Paradigm Spine, unifying its portfolio of posterior dynamic stabilization and controlled motion technologies under its SMART Solutions™ strategy to address the continuum of lumbar spinal stenosis ("LSS") and degenerative disc disease ("DDD")...

    Comments on Companion Spine Announces Completion of Paradigm Spine Integration, Establishing a Unified Global Leader in Posterior Dynamic and Controlled Motion Spine Solutions
  10. Transpharmation Ltd. anuncia la adquisición estratégica de OrganoTherapeutics SARL (opens in a new tab)

    Transpharmation Ltd. via PR Newswire

    TORONTO, 28 de octubre de 2026 /PRNewswire/ -- Transpharmation Ltd., líder mundial en investigación preclínica por contrato —con un enfoque científico— en los ámbitos de la neurociencia, el dolor y las enfermedades metabólicas, se complace en anunciar la adquisición de OrganoTherapeutics...

    Comments on Transpharmation Ltd. anuncia la adquisición estratégica de OrganoTherapeutics SARL

Nothing here is investment advice.